Hongling Peng - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Hongling Peng

Showing results (101-110 of 110) with videos related to

Pageof 11

Sort By:

You have reached the last page of results.This site can display upto 110 results.

Cancer|November 22, 2025

Clinical characteristics and survival outcomes of thymic mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 82 patientsWenyu Shi, Yimin Ren, Shu Liu, et al.

Cancer Letters|August 14, 2021

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myelomaHui Yi, Long Liang, Haiqin Wang, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 21, 2023

A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their SusceptibilitiesJingyao Chen, Siqi Dai, Lei Zhao, et al.

Cancer Letters|March 20, 2022

Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myelomaHaiqin Wang, Xiaojuan Xiao, Zhenzhen Li, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 19, 2026

Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid LeukemiaTing Liu, Xingli Zhao, Xiaohui Suo, et al.

Nucleic Acids Research|March 17, 2023

The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesisZi Wang, Pan Wang, Jieying Zhang, et al.

The Journal of Clinical Investigation|November 26, 2024

IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.

Cancers|March 28, 2024

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell TransplantationWancheng Guo, Christopher Strouse, David Mery, et al.

Annals of Hematology|February 4, 2026

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.

Signal Transduction and Targeted Therapy|July 5, 2026

Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trialFei Li, Keshu Zhou, Wei Xu, et al.

Pageof 11

Search research articles

Showing results (101-110 of 110) with videos related to

Sort By:

Pageof 11

You have reached the last page of results.This site can display upto 110 results.

Cancer|November 22, 2025

Clinical characteristics and survival outcomes of thymic mucosa-associated lymphoid tissue lymphoma: A multicenter analysis of 82 patientsWenyu Shi, Yimin Ren, Shu Liu, et al.

Cancer Letters|August 14, 2021

Albendazole inhibits NF-κB signaling pathway to overcome tumor stemness and bortezomib resistance in multiple myelomaHui Yi, Long Liang, Haiqin Wang, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 21, 2023

A New Type of Endometrial Cancer Models in Mice Revealing the Functional Roles of Genetic Drivers and Exploring their SusceptibilitiesJingyao Chen, Siqi Dai, Lei Zhao, et al.

Cancer Letters|March 20, 2022

Polyphyllin VII, a novel moesin inhibitor, suppresses cell growth and overcomes bortezomib resistance in multiple myelomaHaiqin Wang, Xiaojuan Xiao, Zhenzhen Li, et al.

Clinical Lymphoma, Myeloma & Leukemia|April 19, 2026

Seven-day Venetoclax Combined With Dose-adjusted Intensive Chemotherapy as Induction Treatment in Newly Diagnosed Acute Myeloid LeukemiaTing Liu, Xingli Zhao, Xiaohui Suo, et al.

Nucleic Acids Research|March 17, 2023

The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesisZi Wang, Pan Wang, Jieying Zhang, et al.

The Journal of Clinical Investigation|November 26, 2024

IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cellsZheng Fu, Zineng Huang, Hao Xu, et al.

Cancers|March 28, 2024

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell TransplantationWancheng Guo, Christopher Strouse, David Mery, et al.

Annals of Hematology|February 4, 2026

Daratumumab-based first-line therapy benefit multiple myeloma patients in a real-world setting: a multi-center retrospective propensity score-match studyYun Wang, Xiaoqin Chen, Qi Liang, et al.

Signal Transduction and Targeted Therapy|July 5, 2026

Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trialFei Li, Keshu Zhou, Wei Xu, et al.

Pageof 11